Cover Image
市場調查報告書

慢性脫髓鞘多發性神經炎(CIPD):全球臨床實驗檢討

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 172348
出版日期 內容資訊 英文 94 Pages
訂單完成後即時交付
價格
Back to Top
慢性脫髓鞘多發性神經炎(CIPD):全球臨床實驗檢討 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月30日 內容資訊: 英文 94 Pages
簡介

本報告提供全球主要地區的慢性脫髓鞘多發性神經炎(CIPD)治療藥臨床實驗數和被實驗人數,各階段趨勢,再彙整主要企業和機關,臨床實驗簡介等。

簡介

  • 慢性脫髓鞘多發性神經炎(CIPD)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,慢性脫髓鞘多發性神經炎(CIPD)臨床實驗數量所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,慢性脫髓鞘多發性神經炎(CIPD)臨床實驗數量所佔的比例

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

慢性脫髓鞘多發性神經炎(CIPD)臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • CSL Limited
    • LFB S.A.
    • Biogen Idec Inc.
    • 武田藥品工業
    • Octapharma AG
    • Novartis AG
    • Kedrion S.p.A.
    • Grifols, S.A.
    • Grifols Deutschland Gmbh
    • GeNeuro SA
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Center for Research Resources
    • Aarhus University
    • Erasmus MC
    • State University of New York at Buffalo
    • Stony Brook University
    • University of Cologne
    • Northwestern University
    • Centre Hospitalier Universitaire de Saint Etienne
    • Oregon Health and Science University
    • Rigshospitalet

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2198CTIDB

GlobalData's clinical trial report, "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014" provides data on the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • LFB S.A.
      • Clinical Trial Overview of LFB S.A.
      • Biogen Idec Inc.
      • Clinical Trial Overview of Biogen Idec Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Octapharma AG
      • Clinical Trial Overview of Octapharma AG
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Kedrion S.p.A.
      • Clinical Trial Overview of Kedrion S.p.A.
      • Grifols, S.A.
      • Clinical Trial Overview of Grifols, S.A.
      • Grifols Deutschland Gmbh
      • Clinical Trial Overview of Grifols Deutschland Gmbh
      • GeNeuro SA
      • Clinical Trial Overview of GeNeuro SA
    • Clinical Trial Overview of Top Institutes / Government
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • State University of New York at Buffalo
      • Clinical Trial Overview of State University of New York at Buffalo
      • Stony Brook University
      • Clinical Trial Overview of Stony Brook University
      • University of Cologne
      • Clinical Trial Overview of University of Cologne
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Centre Hospitalier Universitaire de Saint Etienne
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
      • Oregon Health and Science University
      • Clinical Trial Overview of Oregon Health and Science University
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by LFB S.A., 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kedrion S.p.A., 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols Deutschland Gmbh, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by GeNeuro SA, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by State University of New York at Buffalo, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stony Brook University, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*

List of Figures

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top